comparemela.com

Latest Breaking News On - Optiva securities - Page 8 : comparemela.com

Investegate |Asiamet Res Ltd Announcements | Asiamet Res Ltd: 121 Conference Hong Kong Investor Presentation

OKYO Pharma : Director acquires shares - Form 6-K

Director acquires shares London and New York, NY, 29 March, 2023 - OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat. | March 29, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.